Simplex Trading’s Neumora Therapeutics NMRA Stock Holding History

Simplex Trading’s Portfolio NMRA Stock Details NMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$134K	Sell	78,800 -62,300	-44%	-$119K	﹤0.01%	5207
2026 Q1	$275K	Buy	141,100 +140,900	+70,450%	+$365K	﹤0.01%	3917
2025 Q4	$358	Sell	200 -1,000	-83%	-$2.19K	﹤0.01%	8201
2025 Q3	$2K	Buy	+1,200	New	+$1.94K	﹤0.01%	8684
2025 Q1	–	Sell	-276,600	Closed	-$2.93M	–	9264
2024 Q4	$2.93M	Buy	276,600 +265,900	+2,485%	+$3.19M	﹤0.01%	1870
2024 Q3	$141K	Buy	10,700 +3,900	+57%	+$45.5K	﹤0.01%	4876
2024 Q2	$66K	Hold	6,800	–	–	﹤0.01%	5792
2024 Q1	$93K	Buy	6,800 +6,500	+2,167%	+$105K	﹤0.01%	5664
2023 Q4	$5K	Buy	+300	New	+$3.68K	﹤0.01%	7882

Other funds holding NMRA

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

MCMU

MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Iconiq Capital San Francisco, California $3.47B AUM 23.76% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Simplex Trading's NMRA Position: Q2 2026 in Review

Simplex Trading increased its Neumora Therapeutics (NMRA) stake by 55% in Q2 2026, buying an estimated $135K and bringing the position to 199,810 shares worth $340K. The position accounts for ﹤0.01% of the portfolio, ranked #4081.

Simplex Trading first reported a position in NMRA in Q1 2024 and has held it in 7 quarters since. 113 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.

Simplex Trading held 199,810 shares of Neumora Therapeutics worth $340K as of Q2 2026.
Simplex Trading bought 70,654 Neumora Therapeutics shares in Q2 2026, an estimated $135K.
Neumora Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4081 holding.
Simplex Trading first reported a position in Neumora Therapeutics in Q1 2024 and has held it in 7 quarters since.
113 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.